Testing two malaria vaccines for safety and protection in adults
Treatments studied
Part of Infections clinical trials.
This study compares two experimental malaria vaccines to see how safe they are and how well they protect adults. It may help future malaria prevention, and you would be closely monitored, including a malaria “challenge” test if you qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in Tübingen or nearby during the whole study period
- You must be able to follow study visits and instructions, including possible overnight stays for monitoring
- You must agree to let the team contact you by phone anytime during dosing and follow-up
- You must be willing to take the study medicine given with your group and take malaria treatment afterward if needed
- Your weight/health must meet limits: body mass index under 35 and enough hemoglobin (no anemia as defined)
- You must pass the consent quiz and not donate blood during and after the study while eligibility rules apply
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new long-acting malaria prevention injection (MMV371) in healthy adults and adolescents in Rwanda. Researchers will monitor how safe it is and how your body processes it over 24 weeks.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This study gives healthy adults who have never had malaria a controlled infection with the parasite that causes malaria, to see if it is safe and if mosquitoes can pick up the parasite from them. It may help develop new ways to prevent malaria.
This study tests different doses and forms of a malaria vaccine to see which works best and is safest. It may help protect you from malaria for a full year.
This study tests an experimental malaria vaccine (CVD 36000) in healthy volunteers aged 18–50. Researchers will give you the vaccine and later expose you to malaria parasites in a controlled setting to see if the vaccine protects you. This helps develop a safer vaccine for people in malaria-prone countries.
This study tests a new malaria vaccine in healthy adults. You will receive the vaccine and then be exposed to the malaria parasite in a controlled setting to check if the vaccine protects you.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.